A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

September 8, 2008

Researchers Link Gene to Key Antibody Responses

A powerful gene controls the production of antibodies that effectively neutralize human retroviruses such as HIV, according to new laboratory research conducted by scientists at the University of California at San Francisco (UCSF) and the Rocky Mountain Laboratories of National Institute of Allergy and Infectious Diseases (NIAID) in Hamilton, Montana. This finding, the authors write in the September 5 issue of Science, may explain why most humans who are infected with HIV do not make neutralizing antibodies that successfully fight the virus.

Antibodies are key to warding off viral infections, and most vaccines against viral diseases stimulate the body to make antibodies against the target virus. Yet no one knows how to make a vaccine that artificially stimulates the production of antibodies that can readily neutralize HIV, largely because so few HIV-infected people naturally exhibit the type of antibody response needed to control the virus.

Genes play a significant role in producing antibodies that successfully neutralize various infections, including retroviruses. Mice are susceptible to a retrovirus called Friend virus, and the UCSF and NIAID researchers point out that a single gene controls the production of neutralizing antibodies that ultimately allow mice to recover from the infection.

A series of experiments led the researchers to conclude that the gene in question is Apobec3, found in both mice and humans. And not only did their data show that Apobec3 contributes to the early control of Friend virus in mice, but the researchers also discovered that a natural defect in the gene correlated with failure to produce an effective neutralizing antibody response to the virus.

The idea that the gene may play a similar role in producing neutralizing antibodies to HIV is supported in studies showing that human Apobec3 proteins exert anti-HIV activity and that the region of the human chromosome containing this gene influences the ability of the virus to establish infection. Research has also demonstrated that HIV uses one of its own proteins, Vif, to destroy two human Apobec3 proteins. Given that Apobec3 seems to help the immune system make neutralizing antibodies against retroviruses, the destruction of Apobec3 proteins by Vif might help explain why most people do not make neutralizing antibodies against HIV.

Search: Apobec3, UCSF, NIAID, antibodies, Vif, Fried virus, vaccine


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    adoniz89
    san dimas
    California


    Reginaldb06
    los angeles
    California


    gustavthesolid
    New York
    New York


    burke42
    Albany
    New York
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.